Tata Translational Cancer Research Center (TTCRC) is creating an unique interactive environment for clinicians, scientists and industry to work together. The purpose is to deliver a better future for patients with cancer in India. Our aim is to bridge the translational gap that lies between scientific enquiries made at the bedside and the answering of these questions in the laboratory so that we may deliver solutions back to the clinic.
Our mission is to improve the outcome of patients with cancer in eastern India and establish an environment for the training of the next generation of cancer researchers. TTCRC will focus on translational research, bringing problems from the bedside to the laboratory and solutions back to the bedside. Patients with cancer in India often come late to therapy. Thus early detection and prevention are key aims in our programme. Variations in population genetics, environment and health systems mean that successful therapeutic strategies developed in western countries may not always be optimal for Indian patients. As targeted therapy enters clinical practice, we also need to develop approaches that are the most cost effective in situations where resources are limited. The TMC structure and vision of translational health care offer both an excellent clinical environment and a vibrant research environment.
Clinicians, scientists and industry are developing partnerships at TTCRC/TMC so patients not only benefit from modern affordable cancer therapy but we are able to develop cost-effective models of care for Indian patients. This will be based on innovatively designed clinical studies, 2 biomarker analyses and basic research integrated into a modular research theme (see schematic).